Clinical Trials Logo

Amebiasis clinical trials

View clinical trials related to Amebiasis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03491228 Completed - Anaerobic Infection Clinical Trials

Anaemetro I.V. Infusion 500mg Drug Use Investigation

Start date: July 2015
Phase:
Study type: Observational

Secondary Data Collection Study; safety and effectiveness of Anaemetro under Japanese medical practice

NCT ID: NCT03262025 Completed - Laparotomy Clinical Trials

Primary Cecal Pathologies Presenting as Acute Abdomen

Start date: January 1, 2016
Phase: N/A
Study type: Observational

Background: The importance of cecal pathologies lie in the fact that being the first part of large intestine, any disease involving the cecum affects overall functioning of the large bowel. Primary cecal pathologies presenting as acute abdomen have not been described in any previous study in terms of presentation, management and outcome. Objectives: The objective of this study was to identify the reported causes of primary cecal pathologies presenting as acute abdomen and the various causes presenting in Indian setting, to discuss morbidity and mortality associated with cecal pathologies and to critically analyse the various management modalities employed in emergency setting.

NCT ID: NCT02734264 Completed - Amebiasis Clinical Trials

Field Studies of Amebiasis in Bangladesh

Start date: January 2008
Phase: N/A
Study type: Observational

The purpose of this study will be to investigate the incidence of both Amebiasis and cryptosporidiosis in Bangladeshi children and examine genetic variation in innate and adaptive immunity with respect to these infections. Novel diagnostics to these infections will also be investigated.

NCT ID: NCT02680665 Completed - Clinical trials for Intestinal Amebiasis

Ameparomo Capsules 250 mg Drug Use Investigation

Start date: October 19, 2015
Phase:
Study type: Observational

This Study is intended to evaluate the safety and effectiveness of Ameparomo Capsules 250 mg under actual medical practice.

NCT ID: NCT02385058 Completed - Helminthiasis Clinical Trials

Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population

Start date: October 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the efficacy and safety of the combination of mebendazole plus quinfamide for the treatment of intestinal helminthiasis and amoebiasis in Mexican population.

NCT ID: NCT02105714 Completed - Schistosomiasis Clinical Trials

Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders

NIDIAGDigest
Start date: July 2014
Phase: N/A
Study type: Observational

NIDIAG is an international collaboration on integrated diagnosis-treatment platforms, funded by the European Commission (EC). NIDIAG aims to develop an improved, patient-centred system for delivering primary health care in resource-constrained settings. NIDIAG will investigate three clinical syndromes, namely (i) persistent digestive disorders, (ii) persistent fever and (iii) neurological disorders, due to neglected tropical diseases (NTDs). The current study focuses on persistent digestive disorders, which are defined as diarrhoea or abdominal pain that last for at least 2 weeks. While acute diarrhoea has been studied globally, few research activities have focused on the epidemiology, diagnosis and treatment of long-lasting diarrhoeal episodes (2 weeks and longer) in the tropics. The spectrum of possibly involved pathogens includes more than 30 bacterial, parasitic and viral infectious agents. This lack of data may be explained by the fact that people suffering from NTDs might only seek care at a late stage of the disease. Furthermore, health systems in affected regions are often weak and their primary health-care centres are often under-staffed and lack essential diagnostic equipment. The hypothesis of this study is that development of an evidence-based syndromic approach can lead to better diagnosis and management of NTDs in patients with persistent digestive disorders. The study will be carried out in two West African countries (Côte d'Ivoire and Mali) and in two Asian countries (Indonesia and Nepal). The study will follow a "case-control" design and patients and controls will be prospectively enrolled. In order to address the knowledge gaps, three specific objectives will be pursued. First, the contribution of NTDs to the 'persistent digestive disorders syndrome' will be assessed. Second, the value of clinical features and rapid diagnostic tests (RDTs) for the diagnosis of target NTDs that give rise to persistent digestive disorders will be determined. Third, the clinical response to standard empiric and targeted treatment of several NTDs in patients with persistent digestive disorders will be evaluated. These objectives will provide a long-term benefit for the communities by improving the clinical decision-making process for the target NTDs and thus, better diagnostic work-up and patient management can be achieved in the study countries and other similar resource-constrained countries

NCT ID: NCT02089048 Completed - Amoebiasis Clinical Trials

Auranofin PK Following Oral Dose Administration

Start date: April 2, 2014
Phase: Phase 1
Study type: Interventional

Phase I, open-label study in 15 healthy adult subjects receive 6 mg of auranofin orally once every 24 hours for 7days. Blood samples will be taken for 17 weeks following the last dose of auranofin for determination of terminal phase pharmacokinetic parameters. Stool samples will also be obtained for the measurement of gold.

NCT ID: NCT00366730 Completed - Amebiasis Clinical Trials

Study of Nitazoxanide in the Treatment of Amebiasis in Children

Start date: February 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the effect of nitazoxanide suspension in treating diarrhea caused by Entamoeba histolytica in children.

NCT ID: NCT00366236 Completed - Amebiasis Clinical Trials

Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents

Start date: February 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the effect of nitazoxanide tablets in treating diarrhea caused by Entamoeba histolytica in adults and adolescents.